What gram sizes are available for clobetasol (0.05% topical corticosteroid) formulations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Available Gram Sizes for Clobetasol Formulations

Clobetasol propionate 0.05% is available in multiple package sizes ranging from 15 grams to 60 grams for creams and ointments, 25-50 mL for solutions, and various sizes for foam and gel formulations.

Standard Package Sizes by Formulation

Solution (Scalp Application)

  • 25 mL bottles are available for clobetasol propionate topical solution 0.05% 1
  • 50 mL bottles are also manufactured for scalp application 1

Cream and Ointment Formulations

  • 15 grams is a common starting size for localized treatment 2
  • 30 grams is the standard tube size recommended for a 12-week course of vulvar lichen sclerosus when applied once daily initially 2
  • 60 grams tubes are available for more extensive treatment needs 2

Clinical Context for Prescribing Quantities

Condition-Specific Amounts

  • Localized psoriasis or eczema: 15-30 gram tubes are typically sufficient for 2-4 weeks of treatment to limited body areas 2, 3
  • Vulvar lichen sclerosus: A 30-gram tube should last approximately 12 weeks following the standard tapering protocol (once daily × 4 weeks, alternate nights × 4 weeks, twice weekly × 4 weeks) 2
  • Bullous pemphigoid (localized): 10-20 grams daily requires larger quantities; prescribe 140-280 grams for a 2-week course 2, 4
  • Bullous pemphigoid (extensive): 30-40 grams daily necessitates 420-560 grams for a 2-week initial phase 2, 4
  • Scalp psoriasis: 25-50 mL solution bottles are appropriate for 2-4 weeks of twice-daily application 1

Weekly Usage Estimates

  • Maximum safe weekly amount: Do not exceed 50 grams per week for any formulation to minimize systemic absorption and HPA axis suppression 2, 3
  • Emollient usage for comparison: Patients using topical corticosteroids for EGFR-TKI skin reactions require 200-400 grams of emollient per week at twice-daily dosing 5

Practical Prescribing Guidance

Application Amount Reference

  • One fingertip unit (approximately 0.5 grams) covers an area roughly twice the size of an adult palm 2, 3
  • Face and neck: 15-30 grams per 2 weeks 5
  • Both hands: 15-30 grams per 2 weeks 5
  • Both legs: 100 grams per 2 weeks 5
  • Trunk: 100 grams per 2 weeks 5

Insurance Documentation

  • For prior authorization, document the initial 3-month lichen sclerosus course as 30 grams total (0.35 grams per application × 84 applications) 2
  • Maintenance therapy can be documented as 30-60 grams per year for ongoing lichen sclerosus management 2

Important Safety Considerations

  • Prescribing quantities larger than 50 grams per week increases risk of systemic side effects including HPA axis suppression, even with topical application 2, 3, 6
  • Serum clobetasol levels become detectable after application of just 20-30 grams, with corresponding adrenal suppression 6
  • When prescribing large quantities (>200 grams total), ensure the treatment plan includes a specific tapering schedule to avoid prolonged continuous use 2, 4

References

Guideline

Clobetasol Propionate Treatment Protocols

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clobetasol 0.05% Treatment Protocol for Limited‑Area Plaque Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clobetasol Propionate Gel Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.